Edwards Lifesciences shows prevailing Real Value of $117.56490000000001 per share. The current price of the firm is $141.0. At this time the firm appears to be over valued. Macroaxis computes value of Edwards Lifesciences from reviewing the firm fundamentals such as Shares Outstanding of 210.02M, Profit Margin of
16.99% and Current Valuation of 29.28B as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to go long with undervalued instruments and to sell out overvalued instruments since at some point assets prices and their ongoing real values will submerge.
Valuation Drivers Correlation
|Time Horizon||30 Days Login to change|
Edwards Lifesciences Corporation is rated # 4 in price to earning category among related companies. It is rated # 3 in price to book category among related companies fabricating about 0.19 of Price to Book per Price to Earning. The ratio of Price to Earning to Price to Book for Edwards Lifesciences Corporation is roughly 5.22